Profile data is unavailable for this security.
About the company
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
- Revenue in USD (TTM)6.00k
- Net income in USD-4.03m
- Incorporated2005
- Employees1.00
- LocationAlaunos Therapeutics Inc501 E Las Olas Blvd, Suite 300FORT LAUDERDALE 33301United StatesUSA
- Phone+1 (617) 259-1970
- Fax+1 (617) 241-2855
- Websitehttps://alaunos.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomx Inc | 0.00 | -36.20m | 6.96m | 20.00 | -- | -- | -- | -- | -23.69 | -23.69 | 0.00 | -0.817 | 0.00 | -- | -- | 0.00 | -147.70 | -62.93 | -210.64 | -78.33 | -- | -- | -- | -- | -- | -41.56 | -- | -- | -- | -- | -104.20 | -- | -71.20 | -- |
| Aspire Biopharma Holdings Inc | 1.94k | -28.70m | 6.98m | -- | -- | -- | -- | 3,755.16 | -65.96 | -65.96 | 0.0022 | -9.26 | 0.0004 | -- | -- | -- | -633.21 | -- | -- | -- | 45.36 | -- | -1,479,598.00 | -- | 0.1708 | -6.20 | -- | -- | -- | -- | -380.85 | -- | -- | -- |
| Pharmacyte Biotech Inc | 0.00 | -8.98m | 6.99m | 2.00 | -- | 0.1343 | -- | -- | -1.32 | -1.32 | 0.00 | 5.38 | 0.00 | -- | -- | 0.00 | -12.74 | 7.21 | -13.51 | 7.54 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 235.53 | -- | -- | -- |
| Quince Therapeutics Inc | 0.00 | -56.98m | 7.00m | 36.00 | -- | 5.08 | -- | -- | -1.22 | -1.22 | 0.00 | 0.0194 | 0.00 | -- | -- | 0.00 | -48.20 | -42.95 | -55.60 | -46.33 | -- | -- | -- | -- | -- | -- | 0.943 | -- | -- | -- | -81.07 | -- | 36.12 | -- |
| Alaunos Therapeutics Inc | 6.00k | -4.03m | 7.12m | 1.00 | -- | 2.61 | -- | 1,234.95 | -2.29 | -2.29 | 0.0034 | 1.27 | 0.0017 | -- | -- | 6,000.00 | -110.67 | -63.80 | -145.65 | -77.93 | -- | -- | -67,083.34 | -7,084.74 | -- | -- | 0.00 | -- | 100.00 | -- | 86.68 | -- | -- | -- |
| Theriva Biologics Inc | 0.00 | -26.19m | 7.14m | 22.00 | -- | 0.3039 | -- | -- | -5.53 | -5.53 | 0.00 | 0.6539 | 0.00 | -- | -- | 0.00 | -73.83 | -37.94 | -99.55 | -42.02 | -- | -- | -- | -- | -- | -- | 0.2025 | -- | -- | -- | -39.81 | -- | -- | -- |
| Intelligent Bio Solutions Inc | 3.58m | -11.29m | 7.22m | 16.00 | -- | 0.4979 | -- | 2.00 | -15.13 | -15.13 | 4.65 | 8.96 | 0.272 | 2.98 | 9.91 | 223,832.50 | -86.08 | -73.55 | -132.01 | -123.30 | 46.21 | -- | -316.50 | -476.22 | 2.26 | -241.14 | 0.0012 | -- | -1.90 | 74.49 | -4.06 | -- | -- | -- |
| Synlogic Inc | 0.00 | -3.23m | 7.25m | 1.00 | -- | 0.7365 | -- | -- | -0.2625 | -0.2625 | 0.00 | 0.8826 | 0.00 | -- | -- | 0.00 | -17.30 | -44.41 | -27.54 | -50.06 | -- | -- | -- | -3,944.49 | -- | -- | 0.00 | -- | -99.76 | -67.55 | 61.88 | -- | -59.28 | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 7.29m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Aptevo Therapeutics Inc | 0.00 | -27.95m | 7.30m | 37.00 | -- | 0.3128 | -- | -- | -306,220.00 | -306,220.00 | 0.00 | 22.67 | 0.00 | -- | -- | 0.00 | -125.64 | -47.17 | -172.77 | -82.66 | -- | -- | -- | -487.43 | -- | -- | 0.00 | -- | -- | -- | -29.38 | -- | -- | -- |
| Mustang Bio Inc | 0.00 | -2.34m | 7.37m | 6.00 | -- | 0.7152 | -- | -- | -47.37 | -47.37 | 0.00 | 1.34 | 0.00 | -- | -- | 0.00 | -17.59 | -70.16 | -224.95 | -83.31 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 69.47 | -- | -- | -- |
| TRON Group Inc | 1.01m | -549.47k | 7.38m | 50.00 | -- | -- | -- | 7.31 | -0.0034 | -0.0034 | 0.0062 | -0.0508 | -- | -- | -- | 20,191.00 | -- | -- | -- | -- | 60.28 | -- | -110.51 | -- | 0.0417 | -433.32 | -- | -- | 0.3272 | -- | -39.70 | -- | -- | -- |
| Calcimedica Inc | 0.00 | -23.06m | 7.43m | 14.00 | -- | -- | -- | -- | -1.60 | -1.60 | 0.00 | -0.0188 | 0.00 | -- | -- | 0.00 | -148.18 | -58.12 | -194.91 | -64.99 | -- | -- | -- | -- | -- | -- | 1.03 | -- | -- | -- | 60.12 | -- | -57.90 | -- |
Data as of Mar 02 2026. Currency figures normalised to Alaunos Therapeutics Inc's reporting currency: US Dollar USD
4.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Dec 2025 | 21.35k | 0.96% |
| Geode Capital Management LLCas of 31 Dec 2025 | 19.74k | 0.88% |
| Two Sigma Investments LPas of 31 Dec 2025 | 18.59k | 0.83% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 15.50k | 0.69% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 14.06k | 0.63% |
| HRT Financial LPas of 31 Dec 2025 | 12.60k | 0.57% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 1.65k | 0.07% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 1.24k | 0.06% |
| Tower Research Capital LLCas of 31 Dec 2025 | 1.08k | 0.05% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 1.04k | 0.05% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
